Evidence map›Paper›PMID 27736888›Full record

ArticlePloS one2016

A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images.

Attila Forgacs, Hermann Pall Jonsson, Magnus Dahlbom, Freddie Daver, Matthew D DiFranco, Gabor Opposits, Aron K Krizsan, Ildiko Garai, Johannes Czernin, Jozsef Varga and 2 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Repeatability and Reproducibility of Radiomic Features: A Systematic Review.International journal of radiation oncology, biology, physics · 2018
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Quantitative accuracy of radiomic features of low-doseTranslational cancer research · 2020
    Article
  17. Article
  18. Radiogenomics Based on PET Imaging.Nuclear medicine and molecular imaging · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Attila ForgacsScanomed Nuclear Medicine Center, Debrecen, Debrecen, Hungary.
Hermann Pall JonssonDepartment of Nuclear Medicine, Faculty of Medicine, University of Debrecen, Hungary.
Magnus DahlbomAhmanson Biological Imaging Center, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California at Los Angeles, California, United States of America.
Freddie DaverAlfred Mann Institute for Biomedical Engineering, University of Southern California, Los Angeles, California, United States of America.
Matthew D DiFrancoQuantitative Imaging and Medical Physics at Medical University of Vienna, Vienna, Austria.
Gabor OppositsDepartment of Nuclear Medicine, Faculty of Medicine, University of Debrecen, Hungary.
Aron K KrizsanDepartment of Nuclear Medicine, Faculty of Medicine, University of Debrecen, Hungary.
Ildiko GaraiScanomed Nuclear Medicine Center, Debrecen, Debrecen, Hungary.
Johannes CzerninAhmanson Biological Imaging Center, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California at Los Angeles, California, United States of America.
Jozsef VargaDepartment of Nuclear Medicine, Faculty of Medicine, University of Debrecen, Hungary.
Lajos TronDepartment of Nuclear Medicine, Faculty of Medicine, University of Debrecen, Hungary.
Laszlo BalkayDepartment of Nuclear Medicine, Faculty of Medicine, University of Debrecen, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Textural analysis might give new insights into the quantitative characterization of metabolically active tumors. More than thirty textural parameters have been investigated in former F18-FDG studies already. The purpose of the paper is to declare basic requirements as a selection strategy to identify the most appropriate heterogeneity parameters to measure textural features. Our predefined requirements were: a reliable heterogeneity parameter has to be volume independent, reproducible, and suitable for expressing quantitatively the degree of heterogeneity. Based on this criteria, we compared various suggested measures of homogeneity. A homogeneous cylindrical phantom was measured on three different PET/CT scanners using the commonly used protocol. In addition, a custom-made inhomogeneous tumor insert placed into the NEMA image quality phantom was imaged with a set of acquisition times and several different reconstruction protocols. PET data of 65 patients with proven lung lesions were retrospectively analyzed as well. Four heterogeneity parameters out of 27 were found as the most attractive ones to characterize the textural properties of metabolically active tumors in FDG PET images. These four parameters included Entropy, Contrast, Correlation, and Coefficient of Variation. These parameters were independent of delineated tumor volume (bigger than 25-30 ml), provided reproducible values (relative standard deviation< 10%), and showed high sensitivity to changes in heterogeneity. Phantom measurements are a viable way to test the reliability of heterogeneity parameters that would be of interest to nuclear imaging clinicians.

Indexed as

Fluorodeoxyglucose F18HumansLungLung NeoplasmsPhantoms, ImagingPositron Emission Tomography Computed TomographyRadiopharmaceuticalsReproducibility of ResultsRetrospective StudiesTumor BurdenFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID27736888
PMCPMC5063296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.